Oncology Treatment & Patient Outcomes
Treatment journeys, symptom burden and patient-reported outcomes, with clinical and molecular context assessed by cohort.
Define the corpus
Scope an oncology corpus around treatment experience, supportive care and outcomes reported between clinical encounters. Clinical records, imaging reports and molecular testing records can be evaluated as separate additions to a defined cohort.
Fields to assess
- Treatment timelines and medication records
- Patient-reported symptoms and treatment burden
- Patient-reported functioning and supportive-care needs
- Eligible laboratory, imaging and genetic or molecular test reports
Field-level coverage, missingness and provenance are confirmed during feasibility review. Listed modalities are not a promise of availability.
Project applications
- Treatment experience and symptom burden
- Supportive-care outcomes
- Oncology cohort feasibility
- Evaluation of clinical summarization models
Data interpretation
Test reports do not imply access to raw sequencing, variant files or original imaging studies. Each modality and its permitted uses require separate verification.
Cohort and delivery specification
Request the condition definition, unique participant count, geography, observation period, follow-up distribution, field coverage and update schedule. The specification distinguishes self-reported observations, device measurements and clinical-record-derived fields.
Clinical coding, measurement units, data dictionaries, missingness and de-identification are reviewed for the proposed delivery. Clinical images and reports are assessed separately from original DICOM studies; genetic test summaries are assessed separately from raw variants, sequencing and omics matrices.
Licensing and due diligence
Annual licenses, defined-project access and refreshes can be discussed after feasibility review. Research, AI evaluation, model training, derivative models, sublicensing and exclusivity require specific written permissions. Patient recontact is not included in an inquiry or implied by a data license.
Source provenance, the legal supplier or controller and its authority to license are disclosed during buyer due diligence. These profiles may draw on overlapping populations; counts are not added across products.
Tell us the cohort you need.
Include conditions, required fields, follow-up and intended use. No patient records are needed to make an inquiry.